Over the past 2 years, a plethora of mucocutaneous manifestations have been described to be associated with coronavirus 2019 (COVID-19) infection. Nail changes attributed to COVID-19 have rarely been documented in the literature. We describe here a unique nail finding ‘transverse erythronychia’ due to COVID-19 and review the literature on the diverse nail pathology attributed to the disease.
PandaMDashSBeheraBet al. Dermatological manifestations associated with COVID-19 infection. Indian J Dermatol2021; 66: 237–45.
2.
KhanIAKarmakarSChakrabortyUet al. Purpura fulminans as the presenting manifestation of COVID-19. Postgrad Med J2021; 97: 473.
3.
BaranR.The red nail—always benign?ActasDermosifiliogr2009; 100: 106–13.
4.
LindsleyCB.Nail-bed lines in Kawasaki disease. Am J Dis Child1992; 146: 659–60.
5.
ChangCBeutlerBDCohenPR.Polydactylous transverse erythronychia: report of a patient with multiple horizontal red bands affecting the fingernails. DermatolTher2017; 7: 255–62.
6.
SiragusaMDel GraccoSEliaMet al. Peculiar dyschromic changes of finger nails in a patient with multiple system atrophy. Int J Dermatol1998; 37: 156–60.
7.
NeriIGuglielmoAVirdiAet al. The red half-moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatol Venereol2020; 34: e663–5.
8.
Méndez-FloresSZaladonisAValdes-RodriguezR.COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign. Int J Dermatol2020; 59: 1414.
9.
TammaroAAdebanjoGARErasmusHPet al. Transverse orange nail lesions following SARS-CoV-2 infection. Dermatol Ther2021; 34: 2–3.
10.
SenturkNOzdemirH.Onychomadesis following COVID-19 infection: is there a relationship?Dermatol Ther2020; 33: e14309.
11.
IdeSMoriokaSInadaMet al. Beau’s lines and leukonychia in a COVID-19 patient. Intern Med2020; 59: 3259.
12.
Fernandez-NietoDJimenez-CauheJOrtega-QuijanoDet al. Transverse leukonychia (Mees’ lines) nail alterations in a COVID-19 patient. Dermatol Ther2020; 33: e13863.
13.
AlobaidaSLamJM.Beau lines associated with COVID-19. CMAJ2020; 192: E1040.
